FR2138290A1 - Arginine methaqualone phosphate - with prolonged hypnotic and sedative activity - Google Patents
Arginine methaqualone phosphate - with prolonged hypnotic and sedative activityInfo
- Publication number
- FR2138290A1 FR2138290A1 FR7118494A FR7118494A FR2138290A1 FR 2138290 A1 FR2138290 A1 FR 2138290A1 FR 7118494 A FR7118494 A FR 7118494A FR 7118494 A FR7118494 A FR 7118494A FR 2138290 A1 FR2138290 A1 FR 2138290A1
- Authority
- FR
- France
- Prior art keywords
- methaqualone
- phosphate
- arginine
- hypnotic
- prolonged
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- JEYCTXHKTXCGPB-UHFFFAOYSA-N Methaqualone Chemical compound CC1=CC=CC=C1N1C(=O)C2=CC=CC=C2N=C1C JEYCTXHKTXCGPB-UHFFFAOYSA-N 0.000 title abstract 5
- 229960002803 methaqualone Drugs 0.000 title abstract 5
- 229910019142 PO4 Inorganic materials 0.000 title abstract 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 title abstract 4
- 239000010452 phosphate Substances 0.000 title abstract 4
- 230000000147 hypnotic effect Effects 0.000 title abstract 3
- 239000004475 Arginine Substances 0.000 title abstract 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title abstract 2
- 230000002035 prolonged effect Effects 0.000 title abstract 2
- 230000001624 sedative effect Effects 0.000 title abstract 2
- 241000699670 Mus sp. Species 0.000 abstract 1
- 230000002045 lasting effect Effects 0.000 abstract 1
- CCTIOCVIZPCTGO-BYPYZUCNSA-N phosphoarginine Chemical compound OC(=O)[C@@H](N)CCCNC(=N)NP(O)(O)=O CCTIOCVIZPCTGO-BYPYZUCNSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7118494A FR2138290A1 (en) | 1971-05-21 | 1971-05-21 | Arginine methaqualone phosphate - with prolonged hypnotic and sedative activity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7118494A FR2138290A1 (en) | 1971-05-21 | 1971-05-21 | Arginine methaqualone phosphate - with prolonged hypnotic and sedative activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2138290A1 true FR2138290A1 (en) | 1973-01-05 |
| FR2138290B1 FR2138290B1 (OSRAM) | 1974-08-23 |
Family
ID=9077430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7118494A Granted FR2138290A1 (en) | 1971-05-21 | 1971-05-21 | Arginine methaqualone phosphate - with prolonged hypnotic and sedative activity |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2138290A1 (OSRAM) |
-
1971
- 1971-05-21 FR FR7118494A patent/FR2138290A1/fr active Granted
Non-Patent Citations (1)
| Title |
|---|
| NEANT * |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2138290B1 (OSRAM) | 1974-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| USD244494S (en) | Step stool | |
| IL37861A0 (en) | 2-phenyl-as-triazine-3,5(2h,4h)-diones and derivatives thereof and their use for the control of coccidiosis | |
| GB1341794A (en) | Medicament for the treatment of hepatic disorders | |
| FR2138290A1 (en) | Arginine methaqualone phosphate - with prolonged hypnotic and sedative activity | |
| FR2155927A1 (en) | 1-phenylcyclo hexane carboxylic acid esters - with antispasmodic and anticholinergic activity | |
| FR2138488A1 (en) | 1-(5-indanyl)-omega-aminoalkanes - with tranquillizing activity | |
| ES385521A1 (es) | Un metodo para producir un compuesto de azamorfinano. | |
| Bushala | The Motif of Sexual Choice in Horace," Satire" 1.2 | |
| USD211193S (en) | Game board | |
| Guy | MAN AND HIS TIME: THREE COMTEMPORARY THEOLOGICAL INTERPRETATIONS | |
| FR2124101A1 (en) | Sleep-inducing compns contng salicylamide - and glyceryl guaiacolate | |
| USD231090S (en) | Ski-board | |
| GB1250279A (OSRAM) | ||
| FR2077856A1 (en) | 4-phenylcarbonylmethyl pyrimidines - with analgesic antiinflammatory,hypotensive and spasmolytic activity | |
| Laurence | Basic NHS Costs Para-seltzer tablets (100)€ 1.98 Paracetamol tablets BP (100) 33p Panodol effervescent tablets (24) 23P | |
| FR2106553A1 (en) | Pvp/medicament compsns - giving better oral absorption by increasing the solubility in gastro-intestinal fluids | |
| FR2126077A1 (en) | Ethyl (3, 5-diethoxy-phenoxy)isobutyrate - as hypocholesteremic | |
| Hoxworth | A case presentation of the treatment of dyspareunia. | |
| HOLMES III | The expression of the ineffable: the dialogue between theology and culture in contemporary American society | |
| Stroker | The Formation of Secondary Sayings of Jesus | |
| 木内晶子 | Bed side teaching | |
| Stojiljkovic | A sociotherapeutic approach in social psychiatry. | |
| HAIGHT | AN UNDERSTANDING OF DOGMA: A STUDY OF THE NOTION OF DOGMA IN FRENCH MODERNISM. | |
| FR2097063A1 (en) | Heptaminol salts - with analeptic and sedative action | |
| BE757336A (en) | 5-butyl-and5-pentyl-picolinic acids active - as dopamene-b-hydroxylase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |